Juefeng Wan
Impact in
- Oncology top 10%
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Treatments and Studies
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
-
- Cancer Genomics and Diagnostics
Papers in
- Co-authors
- Zhen Zhang (24 shared papers)Guichao Li (9 shared papers)Lijun Shen (29 shared papers)Ji Zhu (11 shared papers)Yaqi Wang (21 shared papers)Fan Xia (20 shared papers)Sanjun Cai (7 shared papers)Hui Zhang (20 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Frontiers in Oncology (5 papers)BMJ Open (2 papers)Annals of Oncology (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Juefeng Wan
42 papers receiving 660 citations
Peers
Comparison fields: 5 of 70
- Oncology 327
- Cancer Research 122
- Pathology and Forensic Medicine 64
- Health Informatics 5
- Pulmonary and Respiratory Medicine 111
Countries citing papers authored by Juefeng Wan
This map shows the geographic impact of Juefeng Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juefeng Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juefeng Wan more than expected).
Fields of papers citing papers by Juefeng Wan
This network shows the impact of papers produced by Juefeng Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juefeng Wan. The network helps show where Juefeng Wan may publish in the future.
Co-authors
The 25 scholars most cited alongside Juefeng Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 101 | |
| 2 | 2023 | 52 | |
| 3 | 2012 | 39 | |
| 4 | 2014 | 37 | |
| 5 | 2016 | 37 | |
| 6 | 2015 | 33 | |
| 7 | 2019 | 32 | |
| 8 | 2022 | 32 | |
| 9 | 2015 | 32 | |
| 10 | 2022 | 32 | |
| 11 | 2021 | 24 | |
| 12 | 2017 | 23 | |
| 13 | 2022 | 20 | |
| 14 | 2022 | 19 | |
| 15 | 2021 | 18 | |
| 16 | 2020 | 16 | |
| 17 | BH3 mimetic ABT-737 sensitizes colorectal cancer cells to ixazomib through MCL-1 downregulation and autophagy inhibition. | 2016 | 11 |
| 18 | 2014 | 10 | |
| 19 | 2020 | 9 | |
| 20 | 2016 | 8 |
About Juefeng Wan
Juefeng Wan is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology, having authored 50 papers that have together received 666 indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (17 papers), Colorectal and Anal Carcinomas (9 papers), Colorectal Cancer Treatments and Studies (9 papers), Cancer Genomics and Diagnostics (5 papers), Gastric Cancer Management and Outcomes (4 papers), Cancer Cells and Metastasis (3 papers), Radiomics and Machine Learning in Medical Imaging (3 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Oncology (327 citations), Cancer Research (122 citations), Pathology and Forensic Medicine (64 citations), Health Informatics (5 citations) and Pulmonary and Respiratory Medicine (111 citations). Juefeng Wan has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhen Zhang, Guichao Li, Lijun Shen, Ji Zhu, Yaqi Wang, Fan Xia, Sanjun Cai, Hui Zhang, Lifeng Yang and Ye Xu. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, BMJ Open, Annals of Oncology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.